Diamedica Therapeutics Stock Market Value
| DMAC Stock | USD 8.76 0.23 2.70% |
| Symbol | DiaMedica |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
DiaMedica Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DiaMedica Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DiaMedica Therapeutics.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in DiaMedica Therapeutics on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding DiaMedica Therapeutics or generate 0.0% return on investment in DiaMedica Therapeutics over 90 days. DiaMedica Therapeutics is related to or competes with Altimmune, Galectin Therapeutics, EnGene Holdings, Annexon, Alpha Tau, Frequency Therapeutics, and Design Therapeutics. DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney... More
DiaMedica Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DiaMedica Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DiaMedica Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.49 | |||
| Information Ratio | 0.0891 | |||
| Maximum Drawdown | 24.12 | |||
| Value At Risk | (6.47) | |||
| Potential Upside | 7.69 |
DiaMedica Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DiaMedica Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DiaMedica Therapeutics' standard deviation. In reality, there are many statistical measures that can use DiaMedica Therapeutics historical prices to predict the future DiaMedica Therapeutics' volatility.| Risk Adjusted Performance | 0.0868 | |||
| Jensen Alpha | 0.3271 | |||
| Total Risk Alpha | 0.0363 | |||
| Sortino Ratio | 0.0908 | |||
| Treynor Ratio | 0.2241 |
DiaMedica Therapeutics January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0868 | |||
| Market Risk Adjusted Performance | 0.2341 | |||
| Mean Deviation | 3.26 | |||
| Semi Deviation | 4.22 | |||
| Downside Deviation | 4.49 | |||
| Coefficient Of Variation | 936.24 | |||
| Standard Deviation | 4.57 | |||
| Variance | 20.92 | |||
| Information Ratio | 0.0891 | |||
| Jensen Alpha | 0.3271 | |||
| Total Risk Alpha | 0.0363 | |||
| Sortino Ratio | 0.0908 | |||
| Treynor Ratio | 0.2241 | |||
| Maximum Drawdown | 24.12 | |||
| Value At Risk | (6.47) | |||
| Potential Upside | 7.69 | |||
| Downside Variance | 20.15 | |||
| Semi Variance | 17.81 | |||
| Expected Short fall | (3.74) | |||
| Skewness | (0.26) | |||
| Kurtosis | 1.58 |
DiaMedica Therapeutics Backtested Returns
DiaMedica Therapeutics appears to be slightly risky, given 3 months investment horizon. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12 % return per unit of standard deviation over the last 3 months. By reviewing DiaMedica Therapeutics' technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please utilize DiaMedica Therapeutics' Downside Deviation of 4.49, semi deviation of 4.22, and Mean Deviation of 3.26 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DiaMedica Therapeutics holds a performance score of 9. The firm shows a Beta (market volatility) of 2.14, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, DiaMedica Therapeutics will likely underperform. Please check DiaMedica Therapeutics' mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to make a quick decision on whether DiaMedica Therapeutics' price patterns will revert.
Auto-correlation | 0.08 |
Virtually no predictability
DiaMedica Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between DiaMedica Therapeutics time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DiaMedica Therapeutics price movement. The serial correlation of 0.08 indicates that barely 8.0% of current DiaMedica Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Check out DiaMedica Therapeutics Correlation, DiaMedica Therapeutics Volatility and DiaMedica Therapeutics Alpha and Beta module to complement your research on DiaMedica Therapeutics. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.